Sedat Evran's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 1,044 Restricted Stock Units done . Disclosure was reported to the exchange on Oct. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 1,044 | 2,088 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2025 | 1,044 | 2,567 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.90 per share. | 20 Oct 2025 | 335 | 2,232 (0%) | 0% | 321.9 | 107,837 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2025 | 4,110 | 4,110 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2025 | 864 | 1,800 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2025 | 864 | 2,592 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 295.43 per share. | 05 Sep 2025 | 277 | 1,523 (0%) | 0% | 295.4 | 81,834 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 2,918 | 2,918 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,044 | 1,188 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Oct 2024 | 1,044 | 3,132 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Payment of exercise price or tax liability using portion of securities received from the company at price $ 346.37 per share. | 20 Oct 2024 | 335 | 853 (0%) | 0% | 346.4 | 116,034 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 3,456 | 3,456 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 3,535 | 3,535 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc (Class A) | Sedat Evran | EVP, Global Supply Chain | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Oct 2023 | 4,176 | 4,176 | - | - | Restricted Stock Units |